Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib/II Study of BBI608 in Combination With Pembrolizumab in Patients With Metastatic Colorectal Cancer

NCT02851004 is registered in ClinicalTrials.gov with Takayuki Yoshino as lead sponsor.

NCT NCT02851004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02851004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib/II Study of BBI608 in Combination With Pembrolizumab in Patients With Metastatic Colorectal Cancer
Lead sponsor
Takayuki Yoshino
Phase
Phase 1/2
Overall status
Terminated
Start date
October 31, 2016
Completion date
August 23, 2021
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer